Skip to main content

Orgenesis Inc Aims to Strengthen Baltimore’s position in ‘DNA Valley’

Further strengthening the Region’s life sciences ecosystem, Johns Hopkins Medicine and biotech company Orgenesis Inc. are partnering to launch the Maryland Center for Cell Therapy Manufacturing, supported by a $5M matching grant from the State of Maryland. The partnership will allow lab and patient trials to be done in Baltimore instead of outsourced to another city. The new, 7,000 sf facility will be located on Johns Hopkins’ East Baltimore medical campus. Via Learn more, here,

Read More

Subscribe to our mailing list: